1
/
of
0
FDA FAERS Adverse Event Narratives – Semaglutide and Tirzepatide (Feb–Oct 2024)
FDA FAERS Adverse Event Narratives – Semaglutide and Tirzepatide (Feb–Oct 2024)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: I would like to request electronic copies, sent by email, of the summary narratives for the following adverse events related to semaglutide and tirzepatide, the earliest initial FDA received date for which is Feb 10, 2024: (Case ID) 23617491, 23566031, 23512675, 23982216, 23632706, 23617491, 23982216, 24308681, 24180895, 24132568, 24047232
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details